Related Experiment Video
Updated: Jul 5, 2026

07:32
A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
Published on: August 30, 2019
Functional and phenotypic characterization of the humanized BLT mouse model
A K Wege1, M W Melkus, P W Denton
1Department of Internal Medicine, Division of Infectious Diseases Y9.206, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9113, USA,
Current Topics in Microbiology and Immunology
|May 17, 2008
Summary
A new mouse model enables systemic T cell development and function. This breakthrough addresses limitations in studying T cell deficiencies and developing therapies for infections and cancers.
Area of Science:
- Immunology
- Hematology
- Transplantation Biology
Background:
- T cells are crucial for immune responses, and their absence leads to severe infections and cancers.
- Existing animal models inadequately replicate human T cell development (neogenesis) and systemic function.
- Previous attempts using SCID mice with human stem cells or fetal tissues showed limited systemic T cell engraftment.
Purpose of the Study:
- To develop a more effective in vivo model for studying human T cell neogenesis and systemic immune reconstitution.
- To overcome the limitations of previous SCID mouse models in achieving functional human T cell populations.
Main Methods:
- Transplantation of human fetal liver CD34+ hematopoietic stem cells into NOD/SCID mice pre-engrafted with human fetal thymus and liver tissues.
- Evaluation of systemic engraftment and reconstitution of various human immune cell lineages.
- Assessment of T cell function, including activation by human antigen-presenting cells and MHC-restricted responses.
Main Results:
- Successful long-term, systemic T cell homeostasis in the modified NOD/SCID mouse model.
- Systemic repopulation with functional human T cells, B cells, monocytes/macrophages, and dendritic cells.
- Demonstrated ability of developed T cells to be activated and mediate human MHC-restricted immune responses.
Conclusions:
- This novel SCID-hu model provides a robust platform for studying human T cell development and function in vivo.
- The model facilitates research into T cell-related immunodeficiencies and the development of novel therapeutic strategies.
- It represents a significant advancement in creating functional human immune systems within an animal model.
